Dr Stephanie Kuku
Chief Knowledge Officer, Conceivable Life Sciences
Health Technology Executive - Biotech, Health-Tech, Clinical AI; scientific affairs, regulatory, product and go-to-market strategy. Board Trust and Investment Committe King’s Fund. Scientific Committee Prix Galien chaired by Sir Mark Walport. Over 15 years clinical and research experience and trained and worked in the NHS/HCA as a surgical oncologist specialising in women's cancers. Senior Advisor and consultant in Clinical AI/Medical devices at the World Health Organisation’s Department of Digital Health & Innovation. NHS England Clinical Entrepreneur and Honorary Senior Research Fellow at UCL where she was awarded a Doctorate in Clinical Research in Oncology. During her clinical career Stephanie sat on council of a National Cancer Society (BGCS) and was awarded numerous International travelling fellowships to; Memorial Sloane Kettering Cancer Center in New York, Cancer Hospital Pernambuco in Brazil, and Centre du Cancer Oscar Lambret in France. Stephanie is a regular speaker on the future of women’s health, validation of health technology and has hosted a US podcast (HLTH) on themes around technology and the future of health. Stephanie is an angel investor and advisor to health-tech funds in London and New York City. She contributes to advisory boards across the health sector and provides advisory consultancy to a range of organisations.
.png)
.png)
.png)
.jpg)
.jpg)
.jpg)
.png)
.jpg)
